Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 847

1.

Resistance to antiretrovirals in HIV-infected pregnant women.

Weinberg A, Forster-Harwood J, McFarland EJ, Pappas J, Davies JK, Kinzie K, Barr EA, Paul SM, Salbenblatt CR, Soda E, Vazquez A, Levin MJ.

J Clin Virol. 2009 May;45(1):39-42. doi: 10.1016/j.jcv.2009.02.009. Epub 2009 Mar 28.

PMID:
19329355
2.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
3.

Genotypic resistance tests for the management of the HIV-infected pregnant woman.

Bassetti D, Cargnel A.

Scand J Infect Dis Suppl. 2003;106:70-4. Review.

PMID:
15000589
4.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

5.

Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.

Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q.

Int J STD AIDS. 2009 Apr;20(4):249-54. doi: 10.1258/ijsa.2008.008480.

PMID:
19304969
6.

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.

PMID:
18753864
7.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.

PMID:
17489882
8.

Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy.

Lyons FE, Coughlan S, Byrne CM, Hopkins SM, Hall WW, Mulcahy FM.

AIDS. 2005 Jan 3;19(1):63-7. Erratum in: AIDS. 2007 Jul 31;21(12):1671.

PMID:
15627034
9.

Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy.

Clarke JR, Braganza R, Mirza A, Stainsby C, Ait-Khaled M, Wright A, Lyall H, Parker D, McClure MO, Weber JN, Taylor GP.

J Med Virol. 1999 Nov;59(3):364-8.

PMID:
10502270
10.

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.

Arrivé E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, Leroy V, Perre PV, Rouzioux C, Dabis F; Ghent Group on HIV in Women and Children.

Int J Epidemiol. 2007 Oct;36(5):1009-21. Epub 2007 May 28. Review.

PMID:
17533166
11.

Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.

Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, Marazzi MC, Mancini MG, Cusato M, Germano P, Loureiro S, Ceffa S, Regazzi M, Vella S, Palombi L.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):286-91.

PMID:
17146372
12.

Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.

Sitnitskaya Y, Rochford G, Rigaud M, Essajee S, Pollack H, Krasinski K, Borkowsky W.

Clin Infect Dis. 2001 Jul 1;33(1):e3-7. Epub 2001 Jun 6.

PMID:
11389511
13.

Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.

Duran AS, Losso MH, Salomón H, Harris DR, Pampuro S, Soto-Ramirez LE, Duarte G, de Souza RS, Read JS; NISDI Perinatal Study Group.

AIDS. 2007 Jan 11;21(2):199-205.

PMID:
17197811
14.

Response to antiretroviral therapy after a single, peripartum dose of nevirapine.

Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, Stevens L, Chand F, Makhema J, Moffat C, Asmelash A, Ndase P, Arimi P, van Widenfelt E, Mazhani L, Novitsky V, Lagakos S, Essex M.

N Engl J Med. 2007 Jan 11;356(2):135-47.

15.

Strategies to prevent mother-to-child transmission of HIV.

McIntyre J.

Curr Opin Infect Dis. 2006 Feb;19(1):33-8. Review.

PMID:
16374215
16.

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.

Descamps D, Flandre P, Joly V, Meiffrédy V, Peytavin G, Izopet J, Tamalet C, Zeng AF, Harel M, Lastère S, Aboulker JP, Yéni P, Brun-Vézinet F; NOVAVIR (ANRS 073) Study Group.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):464-71. Erratum in: J Acquir Immune Defic Syndr. 2003 Jan;32(1):116..

PMID:
12473833
17.

Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.

Nolan M, Fowler MG, Mofenson LM.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):216-29. Review.

PMID:
12045685
18.

Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission.

Giuliano M, Palmisano L, Galluzzo CM, Amici R, Germinario E, Okong P, Kituuka P, Mmirro F, Magoni M, Vella S.

AIDS. 2003 Jul 4;17(10):1570-2.

PMID:
12824800
19.

Prevention of perinatal HIV transmission during pregnancy.

McGowan JP, Shah SS.

J Antimicrob Chemother. 2000 Nov;46(5):657-68. Review.

PMID:
11062184
20.

Prevalence of HIV-1 drug resistance in antiretroviral-naive pregnant Thai women.

Auswinporn S, Jenwitheesuk E, Panburana P, Sirinavin S, Vibhagool A, Chantratita W.

Southeast Asian J Trop Med Public Health. 2002 Dec;33(4):818-21.

PMID:
12757232

Supplemental Content

Support Center